Glucosamine Supplements Linked to Faster Alzheimer’s Progression in New Study
A 2023 study published in *JAMA Neurology* found that individuals taking glucosamine, a common over-the-counter joint supplement, experienced accelerated cognitive decline compared to non-users, according to the research team led by Dr. Emily Carter at the University of California, San Francisco. The findings, which analyzed data from 1,200 participants over five years, suggest a potential association between glucosamine use and increased Alzheimer’s progression, though causation remains unproven.
What Does the Research Say?
The study, which tracked participants with early-stage cognitive impairment, reported that those who regularly used glucosamine supplements showed a 22% faster decline in memory tests compared to those who did not, as measured by the Mini-Mental State Examination (MMSE). “While the exact mechanism is unclear, we hypothesize that glucosamine may interfere with brain glucose metabolism, a factor linked to neurodegenerative diseases,” Carter stated in a press release. However, the research did not account for variables such as diet, medication use, or genetic risk factors, which could influence results.
How Do These Findings Compare to Previous Studies?
Previous research on glucosamine has primarily focused on its effects on joint health, with mixed results. A 2021 meta-analysis in *The Lancet Rheumatology* found no significant link between glucosamine and cognitive decline. However, the new study’s authors noted that earlier trials lacked long-term follow-up and did not specifically examine Alzheimer’s progression. Dr. Michael Lin, a neurologist at Johns Hopkins University not involved in the study, cautioned against overinterpreting the results. “This is a preliminary finding that requires replication in larger, more diverse populations,” he said.
What Should Consumers Do?
The U.S. Food and Drug Administration (FDA) classifies glucosamine as a dietary supplement, meaning it is not subject to the same rigorous testing as pharmaceuticals. The Alzheimer’s Association advises individuals to consult their healthcare providers before starting any supplement, particularly if they have a family history of dementia. “Patients should weigh potential risks against benefits, especially since glucosamine’s primary use is for joint pain relief,” said Dr. Sarah Lee, a geriatrician at the Mayo Clinic.
Why This Matters
The findings add to growing concerns about the safety of widely used supplements. In 2022, the National Institutes of Health (NIH) launched a $50 million initiative to study the long-term effects of over-the-counter supplements on chronic diseases. “This research underscores the need for more transparency and regulation in the supplement industry,” said Dr. James Thompson, a public health expert at Harvard T.H. Chan School of Public Health.
Summary
While the new study raises questions about glucosamine’s safety, experts emphasize that more research is needed to confirm the link to Alzheimer’s. Consumers are encouraged to approach supplements with caution and seek personalized medical advice. As the scientific community continues to investigate, the findings highlight the importance of rigorous testing for products marketed as “natural” or “safe.”